Dr. Tejas Shah is an expert in validating and reporting various assays related to infectious diseases, oncology, and reproductive health. In addition to his clinical expertise, Dr. Shah is instrumental in developing and executing strategies to build networks with Key Opinion Leaders (KoLs). His efforts are focused on diversifying the use of advanced technologies such as digital droplet PCR (ddPCR), Next-Generation Sequencing (NGS), and Microarrays, along with other emerging diagnostic technologies. Through his dual roles in clinical validation and strategic development, Dr. Shah significantly contributes to advancing diagnostic capabilities and broadening the adoption of cutting-edge technologies in the medical community.